SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo
Jennifer P. Arbitrario, Brian J. Belmont, Marc J. Evanchik, W. Michael Flanagan, Raymond V. Fucini, Stig K. Hansen, Shannon O. Harris, Ahmad Hashash, Ute Hoch, Jennifer N. Hogan, Anthony R. Howlett, JVolume:
65
Language:
english
Pages:
11
DOI:
10.1007/s00280-009-1076-8
Date:
March, 2010
File:
PDF, 453 KB
english, 2010